Takeda Pharmaceutical Company Limited(TAK) Q2
EPS: 1.96 USD; Forecast 0.15 USD
Revenue: 15.29B USD; Forecast 7.34B USD
Reporting period: 2026 Q2 (period ended 2026-09-30)
Release date: 2026-10-29